Trityl Olmesartan Ethyl Ester CAS 144690-33-5 Pite> 98.5% (HPLC) Faktori
Pwovizyon chimik Ruifu Olmesartan Medoxomil Entèmedyè ak kalite siperyè:
4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Etil 4-(1-Idroksi-1-Methylethyl)-2-Propyl-Imidazol-5-Carboxylate CAS 144689-93-0
Dyetil 2-Propyl-1H-Imidazol-4,5-Dicarboxylate CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Asid CAS 761404-85-7
N2-Trityl Olmesartan Asid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Non Chimik | Trityl Olmesartan Ethyl Ester |
Sinonim | Olmesartan Ethyl Ester Trityl Enpurte;Olmesartan Medoxomil enpurte 30;4-(1-Idroksi-1-Methylethyl)-2-propyl-1-[[2'-[1-(Triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]methyl]-1H-Imidazol-5-carboxylic Asid Ethyl Ester;Etil 4-(2-hydroxypropan-2-yl)-2-Propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) )methyl)-1H-imidazol-5-carboxylate |
Nimewo CAS | 144690-33-5 |
Nimewo CAT | RF-PI1873 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C45H44N6O3 |
Pwa molekilè | 716.87 |
Pwen k ap fonn | 161℃ |
Dansite | 1.18±0.1 g/cm3 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou blan |
Pite / Metòd analiz | >98.5% (HPLC) |
Kontni dlo (KF) | <0.50% |
Rezid sou ignisyon | <0.20% |
Enpurte Ⅰ | <0.10% 4-(1-Hydroxy-1-methylpropyl)-2-propyl-1-{[2'-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]-4-yl ]methyl}-1H-imidazol-5-carboxylic etil ester |
Enpurte Ⅱ | <0.10% 4-(1-Methoxy-1-methylethyl)-2-propyl-1-{[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]- 4-yl]methyl}-1H-imidazol-5-carboxylic etil ester |
Enpurte Ⅲ | <0.50% 4-isopropenyl-2-propyl-1-{[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]-4-yl]methyl}-1H -imidazol-5-carboxylic ethyl ester |
Lòt Maksimòm Single Enpurte | <1.00% |
Enpurte total | <1.50% |
Tès Creole | Enterprise Standard |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
Trityl Olmesartan Ethyl Ester (CAS: 144690-33-5) se yon enpurte nan Olmesartan Medoxomil (CAS: 144689-63-4).Olmesartan Medoxomil se yon antagonis reseptè anjyotansin II ki itilize pou trete tansyon wo, ki itilize kòm yon dwòg anti-ipètansif.Olmesartan travay lè li bloke anjyotansin II ak reseptè AT1 nan misk vaskilè yo.Pa bloke lyezon an olye ke sentèz angiotensin II, Olmesartan inibit fidbak negatif regilasyon sou sekresyon renin.Olmesartan Medoxomil te lanse Ozetazini kòm Benicar@, yon tretman oral pou tansyon wo.Olmesartan Medoxomil se rapidman ak konplètman bioaktive pa idroliz ester nan metabolit aktif li yo, olmesartan, pandan absòpsyon nan aparèy gastwoentestinal la.